- Insights, stories & events
- Quality metrics FDA
Can you support quality metrics without MES? Get ready to be graded on a curve!
ArticlePharma & life sciences insights
3 min read
How FDA quality metrics and electronic inspections are driving risk-based oversight - and why digital MES systems are key to staying ahead.


Risk-based inspection schedule
The FDA intends to open the ESG in January 2018 to receive voluntary submissions of data generated in 2017. It expects to begin data analysis when the portal is closed and publish initial findings on its website. The results of the voluntary phase will be evaluated and the FDA will then initiate a notice and comment the rulemaking under its existing statutory authority to develop a mandatory quality metrics reporting program.



